Drug Discovery & Development Virtual Conference - On Demand

Accelerate Your Drug Discoveries with Live Cell Analysis

As the cost of bringing new drugs to market continues to grow, so do the pressures around increasing efficiency and productivity throughout the discovery and development cycle. And, no matter the stage, cell based analysis plays a critical role whether that be in discovery stages where you're identifying new potential targets, in screening where you're modifying the target, or in toxicity studies where you're examining adverse effects on targets.

Agilent, and BioTek, the newest member of the Agilent family, showcase their latest innovations in cell analysis for drug discovery research. View the following BioTek webinar recordings on demand.
 

1. QUBES: A rapid approach for predicting the stability of proteins
   Presenter: Chris Pudney, PhD - Associate Professor of Biophysics, University of Bath; Director, BLOC Laboratories Ltd
    
2. Using Physical Chemistry and a High-Throughput Drug Screen to Find a Drug to Treat Sickle Cell Disease
   Presenter: Emily Dunkelberger, PhD - Staff Scientist, Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
   
   
   WATCH THE RECORDINGS